Mutual Funds

Invesco All Cap Market Neutral Fund

Alternatives | Equity Market Neutral

Objective & Strategy

The fund seeks to provide a positive return over a full market cycle from a broadly diversified portfolio of stocks while seeking to limit exposure to the general risks associated with stock market investing.

Explore High-Conviction Investing with Invesco

Management team

as of 10/31/2017

Top Equity Holdings | View all

  % of Total net assets
MICRON TECHNOLOGY INC 1.95
RH 1.87
SCIENTIFIC GAMES CORP 1.84
CORCEPT THERAPEUTICS INC 1.82
FIBROGEN INC 1.80
KEMET CORP 1.76
HARSCO CORP 1.75
VERTEX PHARMACEUTICALS INC 1.73
BEST BUY CO INC 1.65
IONIS PHARMACEUTICALS INC 1.64

Holdings are subject to change and are not buy/sell recommendations.

as of 11/30/2017 09/30/2017

Average Annual Returns (%)

  Incept.
Date
Max
Load (%)
Since
Incept. (%)
YTD (%) 1Y (%) 3Y (%) 5Y (%) 10Y (%)
NAV 12/17/2013 N/A 2.09 -8.20 -7.97 -0.27 N/A N/A
Load 12/17/2013 5.50 0.64 -13.24 -13.04 -2.15 N/A N/A
Performance quoted is past performance and cannot guarantee comparable future results; current performance may be lower or higher. Investment return and principal value will vary so that you may have a gain or a loss when you sell shares.

Performance shown at NAV does not include applicable front-end or CDSC sales charges, which would have reduced the performance.

Performance figures reflect reinvested distributions and changes in net asset value (NAV) and the effect of the maximum sales charge unless otherwise stated.

Had fees not been waived and/or expenses reimbursed currently or in the past, returns would have been lower.

as of 11/30/2017 09/30/2017

Annualized Benchmark Returns


Index Name 1 Mo (%) 3 Mo (%) 1Y (%) 3Y (%) 5Y (%) 10Y (%)
Citi US Three-Month Treasury Bill Index 0.09 0.27 0.77 0.35 0.23 0.37
Citi US Three-Month Treasury Bill Index 0.09 0.27 0.77 0.35 0.23 0.37
Citi US Three-Month Treasury Bill Index 0.09 0.26 0.64 0.29 0.19 0.42
Citi US Three-Month Treasury Bill Index 0.09 0.26 0.64 0.29 0.19 0.42

Source: FactSet Research Systems Inc.

Source: FactSet Research Systems Inc.

An investment cannot be made directly in an index.

Expense Ratio per Prospectus

Management Fee 0.85
12b-1 Fee 0.25
Other Expenses 0.35
Interest/Dividend Exp 0.00
Total Other Expenses 0.35
Acquired Fund Fees and Expenses (Underlying Fund Fees & Expenses) 0.02
Total Annual Fund Operating Expenses 1.47
Contractual Waivers/Reimbursements -0.02
Net Expenses - PER PROSPECTUS 1.45
Additional Waivers/Reimbursements 0.00
Net Expenses - With Additional Fee Reduction 1.45
This information is updated per the most recent prospectus.

Historical Prices

From   to
No history records found for this date range

Distributions

From   to
    Capital Gains Reinvestment
Price ($)
Ex-Date Income Short Term Long Term
12/13/2016 N/A N/A 0.0058 10.47
12/11/2015 1.3326 N/A N/A 10.57
as of 11/30/2017

Fund Characteristics

3-Year Alpha N/A
3-Year Beta N/A
3-Year R-Squared N/A
Number of Securities N/A
Total Assets $126,163,233.00
Wghtd Med Mkt Cap MM$ $1,452.00

Source: FactSet Research Systems Inc., StyleADVISOR

as of 10/31/2017

Top Equity Holdings | View all

  % of Total net assets
MICRON TECHNOLOGY INC 1.95
RH 1.87
SCIENTIFIC GAMES CORP 1.84
CORCEPT THERAPEUTICS INC 1.82
FIBROGEN INC 1.80
KEMET CORP 1.76
HARSCO CORP 1.75
VERTEX PHARMACEUTICALS INC 1.73
BEST BUY CO INC 1.65
IONIS PHARMACEUTICALS INC 1.64

Holdings are subject to change and are not buy/sell recommendations.

as of 10/30/2017

Portfolio Composition

  % of Total net assets
Percentage of Net Asset (Long) 90.00
Percentage of Net Asset (Short) 90.00
Gross Exposure (Long + Short) 180.00
Net Exposure (Long - Short) 0.00

Gross Exposure represents the absolute exposure of the fund to long and short holdings combined.
Net Exposure represents the difference between long and short holdings exposure for the fund.

as of 10/30/2017

Top 5 Long Positions

  % of Total net assets
MICRON TECHNOLOGY INC 1.95
RH 1.87
SCIENTIFIC GAMES CORP 1.84
CORCEPT THERAPEUTICS INC 1.82
FIBROGEN INC 1.80

Holdings are subject to change and are not buy/sell recommendations

as of 10/30/2017

Top 5 Short Positions

  % of Total net assets
OVERSTOCK.COM INC -1.42
SAREPTA THERAPEUTICS INC -1.38
TESLA INC -1.38
HERTZ GLOBAL HOLDINGS INC -1.37
DYNAVAX TECHNOLOGIES CORP -1.37

Holdings are subject to change and are not buy/sell recommendations

as of 10/30/2017

Equity Sector Breakdown

  % of Total net assets
Sector Long weight (%) Short weight (%)
Consumer Discretionary 17.39 -17.12
Consumer Staples 2.20 -1.58
Energy 6.19 -7.10
Financials 4.48 -5.73
Health Care 33.40 -32.45
Industrials 9.02 -9.03
Information Technology 14.13 -14.97
Materials 2.02 -1.45
Real Estate 1.39 -1.05
Telecommunications 0.33 0.00
Utilities 0.00 0.00

 About risk

Active Trading Risk. Active trading of portfolio securities may result in added expenses, a lower return and increased tax liability.

Derivatives Risk .The value of a derivative instrument depends largely on (and is derived from) the value of an underlying security, currency,commodity, interest rate, index or other asset (each referred to as an underlying asset). In addition to risks relating to the underlying assets, the use of derivatives may include other, possibly greater, risks, including counterparty, leverage and liquidity risks. Counterparty risk is the risk that the counterparty to the derivative contract will default on its obligation to pay the Fund the amount owed or otherwise perform under the derivative contract. Derivatives create leverage risk because they do not require payment up front equal to the economic exposure created by owning the derivative. As a result, an adverse change in the value of the underlying asset could result in the Fund sustaining a loss that is substantially greater than the amount invested in the derivative, which may make the Fund’s returns more volatile and increase the risk of loss. Derivative instruments may also be less liquid than more traditional investments and the Fund maybe unable to sell or close out its derivative positions at a desirable time or price. This risk may be more acute under adverse market conditions, during which the Fund may be most in need of liquidating its derivative positions. Derivatives may also be harder to value, less tax efficient and subject to changing government regulation that could impact the Fund’s ability to use certain derivatives or their cost. The SEC has proposed new regulations related to the use of derivatives and related instruments by registered investment companies. If adopted as proposed, these regulations would limit the Fund’s ability to engage in derivatives transactions and may result in increased costs or require the Fund to modify its investment strategies or to liquidate. Also, derivatives used for hedging or to gain or limit exposure to a particular market segment may not provide the expected benefits, particularly during adverse market conditions. These risks are greater for the Fund than most other mutual funds because the Fund will implement its investment strategy primarily through derivative instruments rather than direct investments in stocks/bonds

Management Risk. The Fund is actively managed and depends heavily on the Adviser’s judgment about markets, interest rates or the attractiveness, relative values, liquidity, or potential appreciation of particular investments made for the Fund’s portfolio. The Fund could experience losses if these judgments prove to be incorrect. Additionally, legislative, regulatory, or tax developments may adversely affect management of the Fund and, therefore, the ability of the Fund to achieve its investment objective. In particular, there is no guarantee that the portfolio manager’s stock selection process will produce a market neutral portfolio that reduces or eliminates the Fund’s exposure to general U.S. stock market risk, sector or industry-specific risk or market capitalization risk. In addition, the Fund’s market neutral investment strategy will likely cause the Fund to underperform the broader U.S. equity market during market rallies. Such underperformance could be significant during sudden or significant market rallies.

Market Risk. The market values of the Fund’s investments, and therefore the value of the Fund’s shares, will go up and down, sometimes rapidly or unpredictably. Market risk may affect a single issuer, industry or section of the economy, or it may affect the market as a whole. Individual stock prices tend to go up and down more dramatically than those of certain other types of investments, such as bonds. During a general downturn in the financial markets, multiple asset classes may decline in value. When markets perform well, there can be no assurance that specific investments held by the Fund will rise in value.

Sector Focus Risk. The Fund may from time to time invest a significant amount of its assets (i.e. over 25%) in one market sector or group of related industries. In this event, the Fund’s performance will depend to a greater extent on the overall condition of the sector or group of industries and there is increased risk that the Fund will lose significant value if conditions adversely affect that sector or group of industries.

Short Position Risk. Because the Fund’s potential loss on a short position arises from increases in the value of the asset sold short, the Fund will incur a loss on a short position, which is theoretically unlimited, if the price of the asset sold short increases from the short sale price. The counterparty to a short position or other market factors may prevent the Fund from closing out a short position at a desirable time or price and may reduce or eliminate any gain or result in a loss. In a rising market, the Fund’s short positions will cause the Fund to underperform the overall market and its peers that do not engage in shorting. If the Fund holds both long and short positions, and both positions decline simultaneously, the short positions will not provide any buffer (hedge) from declines in value of the Fund’s long positions. Certain types of short positions involve leverage,which may exaggerate any losses, potentially more than the actual cost of the investment, and will increase the volatility of the Fund’s returns.

Small- and Mid-Capitalization Companies Risks. Small- and mid-capitalization companies tend to be more vulnerable to changing market conditions, may have little or no operating history or track record of success, and may have more limited product lines and markets, less experienced management and fewer financial resources than larger companies. These companies’ securities may be more volatile and less liquid than those of more established companies, and their returns may vary, sometimes significantly, from the overall securities market.

as of 12/11/2017

CPNAX

NAV Change ($)
$9.56 -0.08
N/As may appear until data is available. Data is usually updated between 3 and 6 p.m. CST.

Fund Details

  • Distribution Frequency Annually
  • NASDAQ CPNAX
  • WSJ Abrev. N/A
  • CUSIP 00888Y391
  • Fund Type Alternative
  • Geography Type Domestic
  • Inception Date 12/17/2013
  • Fiscal Year End 10/31
  • Min Initial Investment $1,000
  • Subsequent Investment $50
  • Min Initial IRA Investment $250
  • Fund Number 1651
  • Tax ID 46-3860607